{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:15:30Z","timestamp":1766132130747,"version":"3.48.0"},"reference-count":8,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"DOI":"10.1515\/hmbci-2025-0060","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:57:47Z","timestamp":1761548267000},"page":"191-194","source":"Crossref","is-referenced-by-count":0,"title":["Standardizing anti-m\u00fcllerian hormone (AMH) and androgen assays: the next Frontier for polycystic ovarian syndrome (PCOS) diagnostic precision"],"prefix":"10.1515","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1928-5048","authenticated-orcid":false,"given":"Pallav","family":"Sengupta","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences , College of Medicine, Gulf Medical University , Ajman , UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7893-5282","authenticated-orcid":false,"given":"Sulagna","family":"Dutta","sequence":"additional","affiliation":[{"name":"Basic Medical Sciences Department , College of Medicine, Ajman University , Ajman , UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"2025121908111618651_j_hmbci-2025-0060_ref_001","doi-asserted-by":"crossref","unstructured":"Teede, HJ, Tay, CT, Laven, JJ, Dokras, A, Moran, LJ, Piltonen, TT, et al.. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol 2023;189:G43\u201364. https:\/\/doi.org\/10.1093\/ejendo\/lvad096.","DOI":"10.1210\/clinem\/dgad463"},{"key":"2025121908111618651_j_hmbci-2025-0060_ref_002","doi-asserted-by":"crossref","unstructured":"Piltonen, TT, Viita-Aho, J, Saarela, U, Melin, J, Forslund, M. Utility of serum anti-m\u00fcllerian hormone measurement as part of polycystic ovary syndrome diagnosis. Semin Reprod Med 2024;42:049\u201359. https:\/\/doi.org\/10.1055\/s-0044-1786731.","DOI":"10.1055\/s-0044-1786731"},{"key":"2025121908111618651_j_hmbci-2025-0060_ref_003","doi-asserted-by":"crossref","unstructured":"Moolhuijsen, LM, Louwers, YV, Laven, JS, Visser, JA. Comparison of 3 different AMH assays with AMH levels and follicle count in women with polycystic ovary syndrome. J\u00a0Clin Endocrinol Metab 2022;107:e3714\u201322. https:\/\/doi.org\/10.1210\/clinem\/dgac370.","DOI":"10.1210\/clinem\/dgac370"},{"key":"2025121908111618651_j_hmbci-2025-0060_ref_004","doi-asserted-by":"crossref","unstructured":"Piltonen, TT, Kinnunen, J, Komsi, E, Kangasniemi, MH, Luiro, K, Rajecki, M, et al.. Prospective validation of anti-m\u00fcllerian hormone cut-off to determine polycystic ovarian morphology: harmonia study. Fertil Steril 2025. https:\/\/doi.org\/10.1016\/j.fertnstert.2025.05.147.","DOI":"10.1016\/j.fertnstert.2025.05.147"},{"key":"2025121908111618651_j_hmbci-2025-0060_ref_005","doi-asserted-by":"crossref","unstructured":"Vale-Fernandes, E, Pignatelli, D, Monteiro, MP. Should anti-m\u00fcllerian hormone be a diagnosis criterion for polycystic ovary syndrome? An in-depth review of pros and cons. Eur J Endocrinol 2025;192:R29\u201343. https:\/\/doi.org\/10.1093\/ejendo\/lvaf062.","DOI":"10.1093\/ejendo\/lvaf062"},{"key":"2025121908111618651_j_hmbci-2025-0060_ref_006","unstructured":"Osman, N. A comparison between the anti-mullerian hormone and ovarian ultrasound for diagnosing polycystic ovary syndrome: a systematic review. Gynecol Reprod Endocrinol Metab 2024;5. https:\/\/doi.org\/10.53260\/grem.245021."},{"key":"2025121908111618651_j_hmbci-2025-0060_ref_007","doi-asserted-by":"crossref","unstructured":"Luque-Ram\u00edrez, M, Mart\u00ednez-Garc\u00eda, M, Insenser, M, Fern\u00e1ndez-Dur\u00e1n, E, Quintero-Tobar, A, Fiers, T, et al.. Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting. J\u00a0Endocrinol Invest 2025;48:131\u201343. https:\/\/doi.org\/10.1007\/s40618-024-02416-0.","DOI":"10.1007\/s40618-024-02416-0"},{"key":"2025121908111618651_j_hmbci-2025-0060_ref_008","unstructured":"Nelson, M, LaRouche, V. Polycystic ovary syndrome: assessment and management guidelines. Am Fam Physician 2024;110:547\u20138."}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2025-0060\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2025-0060\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:11:49Z","timestamp":1766131909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2025-0060\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":8,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2,19]]},"published-print":{"date-parts":[[2025,12,19]]}},"alternative-id":["10.1515\/hmbci-2025-0060"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2025-0060","relation":{},"ISSN":["1868-1891"],"issn-type":[{"type":"electronic","value":"1868-1891"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}